Comprehensive “clinic-on-the-wrist” integration combining hardware, application firmware, and cloud analytics enables customers and partners to deploy more quickly.
FREMONT, CA: Rockley Photonics, a market leader in silicon photonics technology, launches its complete full-stack, “clinic-on-the-wrist” digital health sensor system.
Rockley's sensor module and reference designs for consumer products integrate hardware and application firmware to encourage wearable devices to monitor multiple biomarkers, such as core body temperature, blood pressure, body hydration, alcohol, lactate, and glucose trends.
The full-stack sensing solution from Rockley is comprised of a wristband that houses the sensor module and communicates with custom cloud-based analytical engines via a Rockley smartphone app. In the coming months, the wristband will be used in a series of in-house human studies.
“Our full-stack sensor solution, which brings together optical and electronic hardware, firmware, algorithms, and cloud-based analytics, is an exciting milestone on our roadmap. Our reference designs will significantly aid our customers and partners with the deployment of our technology and accelerate their own scalable, high-volume product delivery,” says Dr. Andrew Rickman, chief executive officer and founder of Rockley Photonics. “We believe that combining machine learning algorithms with continuous monitoring of an extended set of biomarkers from accessible wearable devices will provide new actionable insights to enhance and transform digital healthcare.”
Rockley expects to overcome critical challenges associated with mobile wellness monitoring through its "clinic-on-the-wrist" technology, which utilizes a miniaturized chip solution that provides continuous, non-invasive monitoring of core biomarkers. While many of today's wearable consumer electronics devices monitor heart rate using green light-emitting diodes (LEDs), Rockley's infrared (IR) spectrophotometers can detect and monitor a much broader range of biomarkers, significantly increasing the functionality of wearable devices.
The sensing system's central and distinguishing feature is a non-invasive sensor module based on the spectroscopy technology of the Rockley platform. In contrast to more conventional spectroscopy solutions, which employ broad-spectrum light sources, Rockley's sensor module generates many discrete laser outputs from a single silicon chip covering a broad optical band. The sensor probes non-invasively beneath the skin to analyze constituents and physical phenomena of interest in blood, interstitial fluids, and various layers of the dermis. Historically, such biomarkers were only detectable using bench-top equipment.
Rockley's novel architecture generates several mill watts of optical output power per wavelength channel, which is critical for achieving a small wearable's high signal-to-noise ratio required for signal analysis.
Rockley's initial market focus is on consumer electronics, which has seen significant advancements in digital personal health and fitness monitoring in recent years. Rockley is also actively pursuing collaborations with leading medical device companies to advance digital health applications and improve disease prevention, detection, and management.
In March, Rockley Photonics entered into a definitive agreement to merge with SC Health Corp., a publicly traded special purpose acquisition company. As a result of the transaction, Rockley becomes a publicly-traded company on the New York Stock Exchange under the ticker symbol RKLY.